Departed
Jay Goodman
Director
FRMM ·
FORUM MARKETS Inc
Resignation of Jay Goodman
Ready 8-Ks
50
Latest filing
July 1, 2026, 4:01 PM ET
Top materiality
0.90
Event mix
other_material ×34 · m_and_a ×5 · debt ×5
Sentiment
15 pos · 6 neg · 29 neu
Latest earnings
reported 2025-Q3
Executive change
recent →
Recent 8-K filings for FRMM
Highest-materiality recent filing
ETHZilla issues $350M convertible notes, amends terms; reports buyback and $462M in ETH
- Issued $350M New Convertible Notes on Sept 23, 2025 at 97.25% of principal; 2% interest, matures Sept 23, 2028.
- Conversion price initially $3.05, subject to downward reset; notes secured by $50M ETH and ~$500M cash.
-
Forum Markets Q1 net loss $77.5M, revenue $2.9M; cuts 2026 AUM & revenue outlook; buyback $25M
Revenue $2.9M from aircraft engine leases ($1.1M) and staking ($1.8M); net loss $77.5M on digital asset losses.
-
Forum Markets repurchases 5.65M shares (~28% of outstanding) for $24.1M since April 15
Repurchased and cancelled 5,647,351 shares at avg $4.26/share, total cost ~$24.07M funded from existing cash.
-
FRMM Board reinitiates buyback, forms special committee to evaluate value-maximizing proposals
Reinitiated share repurchase program effective April 15, 2026; Board authorized repurchases possibly exceeding Rule 10b-18 safe harbor.
-
Forum Markets reports FY 2025 rev $6.5M, net loss $450.5M; guides FY 2026 rev $18-26M
FY 2025 revenue $6.5M; Q4 revenue $2.4M; net loss from continuing ops $450.5M primarily from non-recurring stock-based comp.
-
Forum Markets launches $150M revolving loan purchase program, acquires $1.4M in initial loans
Up to $150M five-year revolving commitment to purchase manufactured home chattel loans from Zippy Loans.
-
Forum Markets establishes $10M auto loan warehouse facility, sells 4,200 ETH since Feb 4
Subsidiary ETHZilla Auto Loans entered a $10M revolving warehouse facility with Anchored Finance to fund auto loans from Automatic USA.
-
ETHZilla subsidiary launches Eurus Aero Token I, tokenized jet engine lease offering up to $11.9M
ETHZilla Aerospace LLC launches Eurus Aero Token I, offering accredited investors exposure to jet engine lease cash flows.
-
ETHZilla buys 95 manufactured home loans for $4.7M; yield 10.36%; plans tokenization
Acquired 95 manufactured/modular home loans for $4,674,595 (104% of principal) with a 10.36% annualized yield.
-
ETHZilla acquires two CFM56-7B24 aircraft engines for $12.2M from Avean Engine Solutions
Acquired two CFM56-7B24 aircraft engines for $12.2M cash from Avean Engine Solutions, LLC.
-
ETHZilla redeems $516M principal of convertible notes at 117% premium on Dec 30, 2025
Redeemed all $516,148,000 principal of convertible notes at 117% (plus $87.7M premium and $1.8M accrued interest).
-
ETHZilla sells 24,291 ETH for $74.5M; plans to redeem convertible notes
Sold 24,291 ETH for $74.5M at avg $3,068.69 per ETH.
-
ETHZ stockholders approve convertible note issuance; company plans to redeem notes by Dec 30
Stockholders voted 9.1M for, 3.6M against to approve issuance of shares underlying convertible notes without exchange cap.
-
ETHZilla acquires 15% stake in Zippy for $21.1M to tokenize manufactured home loans
ETHZilla paid $5M cash + $14M common stock to Zippy + $2.1M stock to Zippy shareholders for 15% fully-diluted stake.
-
ETHZilla agrees to redeem $516M in convertible notes at 117% of principal by Dec 30, 2025
Redemption price is 117% of ~$516M aggregate principal plus accrued interest and other amounts.
-
ETHZilla acquires 15% stake in Zippy for $19M (cash + stock); tokenization and board rights
Paid $5M cash + 1,333,332 shares of ETHZ common valued at $10.50/share ($14M) for 2,905,064 Series B-3 Preferred shares of Zippy.
-
ETHZilla acquires 20% stake in Karus for $10M; plans AI-driven auto loan tokenization
Consideration: $3M cash + $7M in ETHZ common stock (453,721 + 181,488 shares) for 20% fully-diluted interest in Karus.
-
ETHZilla rescinds Nov 12 restricted stock awards to CEO and directors after shareholder feedback
Board and Compensation Committee rescinded all restricted stock awards granted to CEO McAndrew Rudisill and each director on Nov 12, 2025, effective immediately.
-
ETHZilla cancels 2.1M treasury shares repurchased at avg $22.04, outstanding reduced to 19.3M
Cancelled 2,099,741 treasury shares previously repurchased under a board-approved program.
-
ETHZilla Q3 revenue $4.1M from staking; John Saunders named CFO
Revenue $4.1M from ETH staking and incentives; adjusted EBITDA $8.5M; net loss $208.7M from non-cash items.
-
ETHZilla sells $40mm ETH to fund share buybacks; repurchased 600k shares for $12mm since Oct 24
Sold $40 million of ETH on Oct 24; net proceeds to be used for share repurchases.
-
ETHZilla acquires 15% stake in Satschel for $15M in cash and stock
ETHZilla invested $5 million cash and $10 million in restricted common stock for 15% of Satschel, owner of Liquidity.io ATS.
-
ETHZilla announces 1-for-10 reverse stock split effective Oct 20, 2025
Reverse split at 1-for-10 ratio reduces outstanding shares from ~160M to ~16M.
-
Stockholders approved increase in authorized common shares from 1B to 5B; amendment filed Oct 8.
-
ETHZilla discloses 102,273 ETH (≈$404M) and $569M cash as of Sep 26, 2025
Total ETH & ETH equivalents: 102,273, valued at approx $404 million.
-
ETHZilla issues $350M convertible notes, amends terms; reports buyback and $462M in ETH
Issued $350M New Convertible Notes on Sept 23, 2025 at 97.25% of principal; 2% interest, matures Sept 23, 2028.
-
ETHZilla issues $350M convertible notes, repurchases 0.5M shares in week
New $350M principal convertible notes at 2% annual interest, issued at 97.25% of face value.
-
ETHZilla director Stephen Shoemaker resigns; CEO Rudisill enters new employment agreement
Stephen H. Shoemaker resigned from the board on Sept 15, 2025, not due to any disagreement with the company.
-
ETHZilla updates on $250M buyback, draws $50M from ETH-backed facility, holds 102K ETH
Board authorized $250M stock repurchase program on Aug 22, 2025; repurchased ~6.0M shares in Sep at avg $2.50/share.
-
ETHZilla secures $80M collateralized ETH loan, appoints McAndrew Rudisill CEO
Entered $80M OTC transaction with Cumberland DRW at 9.90% forward rate, collateralized by ~$125M ETH, settlement Dec 8, 2025.
-
CEO Blair Jordan resigns; McAndrew Rudisill appointed CEO; $1.35M separation cash payment
Blair Jordan resigned as CEO, director and Secretary effective Sept 4, 2025; replaced by Executive Chairman McAndrew Rudisill.
-
ETHZilla to deploy $100M in ETH to EtherFi for liquid restaking; holds 102,246 ETH (~$456M)
Plans to deploy ~$100M of ETH to EtherFi, a liquid restaking protocol, to generate higher yields on treasury holdings.
-
ETHZilla enters up to $10B ATM equity sales agreement with Clear Street LLC
Up to $10.0 billion of common stock may be sold at-the-market through Clear Street as agent
-
ETHZilla authorizes $250M stock buyback; holds 102,237 ETH ($489M) as of Aug 24
Board authorized up to $250M stock repurchase program, effective immediately, expiring June 30, 2026 or earlier if fully utilized or discontinued.
-
ETHZilla enters $156.25M convertible note deal with institutional investor
ETHZilla issued $156.25M senior secured convertible notes at 96% of principal to an institutional investor, closing Aug 8, 2025.
-
ETHZilla issues 1.94M shares on exercise of pre-funded warrants at $0.0001/share
On Aug 14, 2025, warrants for 1,658 shares at $2.65 exercised for cash.
-
ETHZilla closes $2.65/share private placement, issues ~144M shares; appoints new directors
Private Placement closed at $2.65/share: 143.9M shares + 17.5M pre-funded warrants sold to institutional investors.
-
180 Life Sciences rebrands as ETHZilla, begins trading under ETHZ, holds $419M in Ether
Name change from 180 Life Sciences Corp. to ETHZilla Corp. effective Aug 18; tickers ETHZ and ETHZW replace ATNF and ATNFW on Nasdaq.
-
180 Life Sciences enters $500M at-the-market stock sale agreement with Clear Street
Entered into Sales Agreement with Clear Street LLC to sell up to $500M of common stock in ATM offerings.
-
180 Life Sciences to rename as ETHZilla Corp, tickers to ETHZ/ETHZW on Aug 18
Warrant exercises Aug 8-13 raise ~$4.5M from ~2.44M shares at $1.50-$2.65 per share.
-
As of Aug 11, 2025, holds 82,186 ETH ($349M) at avg cost $3,806.71; also $238M in cash equivalents.
-
180 Life Sciences closes $150M convertible note financing; appoints Executive Chairman
Issued $156.25M senior secured convertible notes at 96% of par; conversion price $3.445, subject to reset after 9 months.
-
180 Life Sciences closes $425M private placement to fund Ethereum treasury strategy
Raised $425M gross via PIPE at $2.65 per share; closed Aug 4, 2025.
Executive changes
Role change
Blair Jordan
Principal Accounting/Financial Officer
FRMM ·
FORUM MARKETS Inc
As a result of the Appointment, Blair Jordan, the Chief Executive Officer (Principal Executive Officer) of the Company, who had served as the Principal Accounting/Financial Officer of the Company since October 16, 2024, stepped down from such role, also effective on February 15, 2025.
Appointed
Eric R. Van Lent
Chief Accounting Officer
FRMM ·
FORUM MARKETS Inc
Effective on February 15, 2025, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”), appointed Eric R. Van Lent as the Chief Accounting Officer (Principal Accounting/Financial Officer) of the Company (the “ Appointment ”), which Appointment was effective as of the same date.
Appointed
Blair Jordan
Chief Executive Officer
FRMM ·
FORUM MARKETS Inc
approved the appointment of Mr. Blair Jordan as Chief Executive Officer of the Company (previously Mr. Jordan was Interim Chief Executive Officer of the Company)
Appointed
Ryan Smith
Lead Independent Director
FRMM ·
FORUM MARKETS Inc
appointed independent director Ryan Smith, as Lead Independent Director of the Company
Appointed
Jay Goodman
Director
FRMM ·
FORUM MARKETS Inc
Effective October 24, 2024, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) appointed Jay Goodman (the “ Appointee ” and the “ Appointment ”) as a member of the Board of Directors (“ Board ”), which Appointment was effective as of the same date.
Departed
Ozan Pamir
Chief Financial Officer and Secretary
FRMM ·
FORUM MARKETS Inc
On September 10, 2024, Mr. Ozan Pamir, the Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary of 180 Life Sciences Corp. (the “Company ", “we” and “us”), tendered his resignation to the board of directors of the Company (the “Board”), effective September 30, 2024.
Appointed
Omar Jimenez
Chief Financial Officer and Secretary
FRMM ·
FORUM MARKETS Inc
On September 11, 2024, the Board resolved to appoint Mr. Omar Jimenez, a current member of the Board, as Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary, to fill the vacancy left by Mr. Pamir’s departure, effective on September 30, 2024.
Departed
Dr. Jonathan Rothbard
Chief Scientific Officer
FRMM ·
FORUM MARKETS Inc
On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company effective the same date.
Departed
Dr. James N. Woody
Chief Executive Officer (Principal Executive Officer)
FRMM ·
FORUM MARKETS Inc
On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date
Departed
Sir Marc Feldmann
Director
FRMM ·
FORUM MARKETS Inc
On March 7, 2023, Sir Marc Feldmann, Ph.D. provided notice to the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) of his resignation as a member of the Board of Directors, effective on the same date (March 7, 2024).
Appointed
Omar Jimenez
Director
FRMM ·
FORUM MARKETS Inc
the Board of Directors of the Company appointed Omar Jimenez and Ryan L. Smith (collectively, the “ Appointees ” and the “ Appointments ”) as members of the Board of Directors (“ Board ”), which Appointments were effective as of the same date.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.90 · Median 0.70 · Most common event other_material